Conventional Oncology Products

Our comprehensive portfolio of oncology products includes generic cancer drugs, supportive oncology therapies, and differentiated oncology formulations developed to improve treatment efficacy, safety, and patient compliance. Every product is manufactured under stringent international quality standards, reinforcing our position among reliable oncology drug manufacturers and cancer medicine companies worldwide.

Supported by a strong manufacturing and marketing infrastructure, Wembrace Biopharma collaborates with leading oncology drug companies and research partners to address unmet clinical needs. Through these strategic partnerships, we continue to expand access to effective and affordable cancer treatments, strengthening our mission to make advanced oncology care accessible on a global scale.

Hospital Range
Brand NameMoleculeTherapyDosage FormPackingDescriptionPackage Insert
BLEO-ACE 15 mgBleomycinAnti-neoplasticVial1X15MG

Bleomycin is a chemotherapy agent used to treat various malignancies, including head and neck malignancy, lymphoma, and testicular tumors, among others.

Download PDF
CARBOWEMB 150MG INJ
450MG INJ
600MG INJ
CarboplatinAnti-neoplasticVial1X150MG
1X450MG
1X600MG

Carboplatin is a alkylating agent used to treat advanced ovarian cancer. Early clinical studies of carboplatin were performed in 1982.7Carboplatin was developed as an analog of Cisplatin with reduced nephrotoxicity and vomiting

DOCE-ACE 120 MG
20 MG / 80 MG
DocetaxelAnti-neoplasticVial1X120MG
1X80MG
1X20MG

Docetaxel is a taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer.

Download PDF
GEMWEM RTU 1 GM/200 MGGemcitabine HydrochlorideAnti-neoplasticVial1X1GM
1X200MG

Gemcitabine is a nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer.

Download PDF
IFOWEM 1GM INJ / 2GM INJIFOSFAMIDE with Mesna (100Mg) injectionAnti-neoplasticVial1x1GM
1X2GM

Ifosfamide is an alkylating and immunosuppressive agent used in chemotherapy for the treatment of cancers, including testicular cancer, ovarian cancer, cervical cancer, osteocarcinoma, bladder cancer, small cell lung cancer, and non-Hodgkin's lymphoma. Mesna is used to prevent bleeding in the bladder (hemorrhagic cystitis) during chemotherapy with ifosfamide

Download PDF
WEMPACLI 100 MG/260 MG/30MGPaclitaxelAnti-NeoplasticVial1X100MG
1X260MG
1X30MG

Paclitaxel is a taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer.

Download PDF
XELODACE 500 MGCapecitabineAnti-NeoplasticTablet1X10'S

Capecitabine is a nucleoside metabolic inhibitor indicated to treat different gastrointestinal cancers, including pancreatic cancer and breast cancer.

Download PDF
ASPARAWEM 5000IUL-AsparaginaseAnti-neoplasticVial1X5000IU

Asparaginase Escherichia coli is an asparaginase enzyme from E. coli used as part of treatment regimens for acute lymphoblastic leukemias.

Download PDF
WEBACE 75MG/100 Mg/125 MgPalbociclibTargeted TherapyCapsule1X7x3's

Webace 75MG/ contains Palbociclib. Palbociclib is in a class of medications called kinase inhibitors. Palbociclib is indicated for the treatment of hormone receptor (HR) positive, human epidermal growth 2(HER2) negative locally advanced or metastatic breast cancer.

Download PDF
LTROMB 25MG/ 50MGEltrombopagPlatelet-stimulating agentTablet1X7's

Ltromb 25Mg contains Eltrombopag, which is a thrombopoietin receptor agonist used to treat thrombocytopenia or aplastic anemia associated with various etiologies.

Download PDF
MEGA-ACE 160MGMegesterol acetateAnti-neoplasticTablet1×10's

Megaace 80Mg/ 160MG Megestrol acetate is a progestin that is administered orally to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy.

WEMTANIB 250MGLapatinibAnti-NeoplasticTablet1×30's

Wemtanib 250Mg contains Lapatinib is an antineoplastic agent and tyrosine kinase inhibitor used for the treatment of advanced or metastatic HER-positive breast cancer in patients who received prior chemotherapeutic treatments.

Scroll horizontally to view all columns